title: The Prevalence of Oral Inflammation Among Denture Wearing Patients with Chronic Obstructive Pulmonary Disease.
abstract: Oral inflammation is an important contributor to the etiology of chronic obstructive pulmonary disease, which can impact patient's health status. Previous studies indicate that people with poor oral health are at higher risk for nosocomial pneumonia. Denture wearing is one promoting factor in the development of mucosal infections. Colonization of the denture plaque by Gram-negative bacteria, Candida spp., or other respiratory pathogens, occurring locally, may be aspirated to the lungs. The studies showed that chronic obstructive pulmonary disease (COPD) patients treated with combinations of medicines with corticosteroids more frequently suffer from Candida-associated denture stomatitis. Treatment of oral candidiasis in patients with COPD constitutes a therapeutic problem. Therefore, it is essential to pay attention to the condition of oral mucosal membrane and denture hygiene habits. The guidelines for care and maintenance of dentures for COPD patients are presented in this paper. The majority of patients required improvement of their prosthetic and oral hygiene. Standard oral hygiene procedures in relation to dentures, conducted for prophylaxis of stomatitis complicated by mucosal infection among immunocompromised patients, are essential to maintain healthy oral tissues. The elimination of traumatic denture action in dental office, compliance with oral and denture hygiene, proper use and storage of prosthetic appliances in a dry environment outside the oral cavity can reduce susceptibility to infection. Proper attention to hygiene, including brushing and rinsing the mouth, may also help prevent denture stomatitis in these patients.
authors.affiliation: Department of Prosthodontics, Warsaw Medical University, 59 Nowogrodzka St., 02-005, Warsaw, Poland, dorota.przybylowska@gmail.com.
authors.forename: D
authors.initials: D
authors.lastname: Przybyłowska
authors.forename: R
authors.initials: R
authors.lastname: Rubinsztajn
authors.forename: R
authors.initials: R
authors.lastname: Chazan
authors.forename: E
authors.initials: E
authors.lastname: Swoboda-Kopeć
authors.forename: J
authors.initials: J
authors.lastname: Kostrzewa-Janicka
authors.forename: E
authors.initials: E
authors.lastname: Mierzwińska-Nastalska
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D002175:Candida / Q000254:growth & development; D002180:Candidiasis, Oral / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D003773:Dental Plaque / Q000150:complications / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D003778:Dentures / Q000382:microbiology; D006801:Humans; D009061:Mouth Mucosa / Q000382:microbiology; D009910:Oral Hygiene; D011044:Poland / Q000453:epidemiology; D017410:Practice Guidelines as Topic; D015995:Prevalence; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D013282:Stomatitis, Denture / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents